分享好友 环球市场首页 环球市场分类 切换频道

Infection Control Market

2024-10-0300

Report Overview

Global Infection Control Market size is expected to be worth around USD 511 Billion by 2033 from USD 241.41 Billion in 2023, growing at a CAGR of 7.8% during the forecast period from 2024 to 2033.

This market is being driven by the increasing number of surgical procedures that prevent high-intensity infections.

Infections are usually caused by microorganisms such as bacteria, viruses, parasites or fungi and can range in type from digestive and stomach infections, lung and respiratory infections, eye and ear infections to hospital-acquired infections (HAIs) as well as skin infections or sexually transmitted diseases transmitted via cross contamination between patient skin/surface area/equipment and healthcare personnel

Positive clinical outcomes are thought to explain the high preference for infection control. The COVID-19 pandemic has had a positive impact on market growth. This has led to an increase in sterilization services at hospitals, clinics, and pharmaceutical companies as well as medical device firms. This market report gives a detailed analysis of the Infection Control market size, share, growth opportunities, major factors, key trends, and other key factors.

Infection Control Market Size

Key Takeaways

Type Analysis

In terms of ‘Type’, the ‘Consumables’ segment accounted for 72.5 % of the infection control market’s revenue share in 2023. Because of their constant use and short life spans, consumers are expected to account for the majority market share. More consumables are being used in sterilization, disinfection, and other control procedures.

Consumables are now an integral part of these procedures. As of 2023, personal protective equipment was a large percentage of all consumables. Many healthcare organizations support the use of personal protective equipment and promote its benefits.

Over the forecast period, the ‘Services’ segment is expected to grow at a rapid pace. They encourage adoption by recommending guidelines and suggesting ways to select, assess risk and use rationally. The infection control market players want to reduce healthcare costs and maximize benefits.

This segment is expected to grow the fastest. This includes cost savings, better efficiency of services, and a greater focus on core areas that are vital to a company’s overall profit growth and development.

End-Use Analysis

With respect to ‘End-Use’, the ‘Hospitals’ segment dominated the infection control market and globally accounted for the major revenue share of 42.8% in 2023. This segment is expected to grow at the fastest rate over the forecast period.

The Infection Control Market involves ways of preventing the spread of infectious organisms in places like hospitals, labs and medical device companies. People working at these establishments need to take measures to avoid getting sick or spreading germs to others – infections control products and methods can keep everyone safer by lowering infection risks – hospitals, labs and pharmaceutical labs use infection control measures as do other institutions to keep people healthy and prevent diseases from spreading further.

This large share is mainly due to the high likelihood spread of infection in hospitals through blood-borne or respiratory pathogens. HAIs pose a major challenge and require strict control. One of the main concerns is the high risk of infections by blood-borne pathogens and drug-resistant pathogens.

UTIs can be caused by the frequent use of urinary catheters. According to NCBI research, 25% of all bacterial infection cases are caused by UTIs. These factors will increase this segment’s future growth potential.

Infection Control Market Share

Маrkеt Ѕеgmеntation

Type

Equipment

Services

Consumables

End-use

Driver

Healthcare Awareness Campaign

Restraints

Healthcare Facilities

Opportunity

Technological Advances provide us with a great advantage

Challenge

Rising Pathogens and Antimicrobial-Resistant Infections

Regional Analysis

North America was the most important market for infection control, accounting for 34.8% of total revenues in 2023. This region accounts for a higher share of the infection control market due to its strong collaborations with key market players. This has allowed these players to grow their product portfolios and improve their infection control capabilities. The US is the dominant market due to its greater presence in the region.

Infection control in the Asia Pacific is anticipated to index the highest CAGR over the forecast period. This is due to higher healthcare spending, increased outsourcing, and the unprecedented development of healthcare infrastructures and standards throughout the region.

The Asia Pacific’s growth has also been influenced by the existence of several voluntary and state-funded organizations that strive to improve infection control standards. Market leaders from developed countries are increasingly outsourcing to Asia Pacific companies making it a key growth driver.

The Asia Pacific Society of Infection Control (a Non-Profit Organization) works to create partnerships to improve quality and promote cost efficiency in the region.

Infection Control Market Region

Key Regions and Countries

Key Players Analysis

Major companies like Advanced Sterilization Products and STERUS Corporation have extensive collaboration strategies that are driving competition. These companies are focused on implementing competitive strategies, such as mergers & acquisitions, as well as the development of new products to expand their geographical reach.

Market Key Рlауеrѕ

Recent Developments

点赞 0
举报
收藏 0
评论 0
分享 0